Press Release • March 16th, 2022 Ossium Health Announces FDA Clearance of its Investigational New Drug Application for Treatment of Perianal Fistulizing Crohn’s Disease Learn More
News • July 27th, 2021 LifeGift and Ossium Health Offer Hope with Bone Marrow Clinical Application Learn More
General • April 21st, 2021 Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health Learn More
Clinical Trials • April 15th, 2021 Ossium Health and Columbia University Irving Medical Center Initiate Phase 1 Study Using Bone Marrow Stem Cells to Minimize Immunosuppression Requirements in Intestinal Transplantation Learn More